Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Discover which crypto projects can enhance your investment diversification. Expand your horizons with strategic choices.
24,489 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A surge in investor interest centers on SPCX as SpaceX expands its orbit into launches, satellite networks, and AI ve...
Korean equities ended a choppy week higher after reports that Anthropic and Samsung were in talks. The move capped a ...
Nike's quarterly results offer more than sneaker news. This guide breaks down the numbers, the stock reaction, and ac...
Boise remains a retirement magnet, but costs have risen. With a $900K pot, a paid-off home, and careful tax and cash-...
Small, consistent savings can compound into meaningful retirement wealth. This article breaks down the math behind sa...
A veteran alchemy of service, fundraising and persistence, Lindsey Graham's rise illustrates how personal history int...
Investors in YMAX face layered fees from a fund-of-funds structure. With a 1.33% expense ratio on top of underlying E...
A 65-year-old Bay Area tech veteran considers retirement with a sizeable real estate stake and a $915k retirement cus...
Afriski, Lesotho's country’s only fully operational ski resort, keeps winter tourism alive and feeds local incomes as...
Flat home prices “mirror” a familiar 1990s pattern, signaling subtle shifts for buyers and investors. This article un...
A major share sale spooked investors and pushed Brightstar Lottery stock down. This guide breaks down what happened, ...